$0.61

-0.01 (-1.13%)

7/23/2008 4:00 PM

AtheroGenics, Inc. (AGIX)

CAPS Rating:

The Company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, including coronary heart disease, organ transplant rejection, rheumatoid arthritis and asthma.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

AGIX doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

84 Outperforms

39 Underperforms

All-Stars

17 Outperforms

15 Underperforms

Wall Street

1 Outperforms

2 Underperforms

Members bullish on AGIX are also bullish on:

Members bearish on AGIX are also bearish on:

Ticker Tags

Micro Cap (4824), Biotechnology (294), Rule Breakers Universe (161), Drug Manufacturers - Other (105)
Suggest a tag

AtheroGenics, Inc. At A Glance

Current Price:	$0.61
Last Trade Time:	7/23/2008 4:00 PM
Open:	$0.00
Previous Close:	$0.62
Daily Range:	$0.59 - $0.63
52-Week Range:	$0.35 - $3.32
Volume:	121,623
Market Cap:	$109.44M
P/E Ratio:	0.00
Compare Our Special Broker Offers!

Stock Trends

AGIX VS S&P 500 (SPY)

News & Discussion Boards

Sorry no news articles available for AGIX.

Top Bull Pitch

Recs

3 AtheroGenics, Inc. (AGIX)

Avatar eldemonio (86.04) Submitted: 12/28/07 11:13 AM

At this point what do you have to lose? The stock has just about bottomed out - if it hasn't quite yet bottomed out, you're only losing .38 at the most. Their failed heart drug AGI 1067 that may make a decent add on therapy for type 2 diabetes is in Phase III testing. You still have awhile until ...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

3 AtheroGenics, Inc. (AGIX)

Avatar thenakedtrader (< 20) Submitted: 3/26/07 6:21 PM

Hope springs eternal. Despite the failure of the primary endpt. goals, which spurred a 60+% drop last week, bulls are pinning their hopes on 'promising' secondary goals that will be presented tomorrow at ACC.

I don't hold out much hope... it's customary to pair bad trial re...More

Replies: 0 | Reply | Permalink

CAPS Members

Show Me:

Sort by:

picks per page. CHANGE

Results 1 - 5 of 22 : 1 2 3 4 5 Next »

Recs 3 (AGIX) eldemonio (86.04) Submitted: 12/28/07 11:13 AM : Start Price: $1.69 AGIX Score: -47.46 At this point what do you have to lose? The stock has just about bottomed out - if it hasn't quite yet bottomed out, you're only losing .38 at the most. Their failed heart drug AGI 1067 that may make a decent add on therapy for type 2 diabetes is in Phase III testing. You still have awhile until the company plans to see this drug hit the market - late 2008ish if all goes well. If stumbling blocks arise in the Phase III testing, bail. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 1 (AGIX) sbrooks64 (< 20) Submitted: 10/27/07 2:03 PM : Start Price: $1.65 AGIX Score: -46.32 This stock will double in the next year. It is not for the weak at heart Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (AGIX) mbills2 (61.33) Submitted: 10/17/07 1:02 PM : Start Price: $1.81 AGIX Score: 50.08 who cares Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (AGIX) tharlow (65.24) Submitted: 9/20/07 6:52 PM : Start Price: $1.74 AGIX Score: 48.90 Will be bankrupt soon. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 1 (AGIX) IrixGuy (< 20) Submitted: 9/18/07 9:10 PM : Start Price: $1.75 AGIX Score: -48.72 Watch this baby soar. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Results 1 - 5 of 22 : 1 2 3 4 5 Next »

Wall Street

Results 1 - 3 of 3

picks per page. CHANGE Expand All Pitches Collapse All Pitches

Top Pick	Member Name	Member Rating	Start Date	Call	Time Frame	Start Price	Stock Gain	S&P Gain	Score	Pitch
	TrackFortisBank	98.29	03/19/07 03/19/07		NS	$3.26	-81.29%	-8.10%	+73.19
	TrackJimCramer	81.15	01/11/07 01/11/07		3W	$11.23	-94.57%	-10.24%	+84.33
	TrackFirstAlbany	75.89	12/07/06 12/07/06		NS	$12.00	-94.92%	-9.82%	-85.10
	TrackZacks	90.45			3M	$0.87	-29.89%	-3.55%	+26.33

Results 1 - 3 of 3

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.